Background: Plasma phospholipid transfer protein (PLTP) plays a central role in the remodeling of HDLs. Reliable and accurate methods for assaying PLTP concentration are required. Methods: A sandwich ELISA for PLTP has been developed, using two monoclonal antibodies against recombinant human PLTP (rhPLTP) expressed in Chinese hamster ovary cells. The ELISA allows for the quantification of PLTP in the range 0.625-15.0 ng/assay (1.2-30.0 mg/L). Intra-and interassay CVs were <3.0% and <4.2% respectively. The assay was used to quantify plasma PLTP concentrations in 132 Japanese subjects (75 males and 57 females). Results: PLTP concentrations were 12.0 ؎ 3.0 mg/L (mean ؎ SD; range, 4.9 -20.5 mg/L). No sex difference was observed. Plasma PLTP concentration was positively correlated with HDL-cholesterol (r ‫؍‬ 0.72; P <0.001), apolipoprotein (apo) A-I (r ‫؍‬ 0.62; P <0.001) and HDL 2 -cholesterol (r ‫؍‬ 0.72; P <0.001), and was negatively correlated with triacylglycerol (r ‫؍‬ ؊0.45; P <0.001). There was no correlation with plasma apo A-II. These results agree with other evidence that plasma PLTP is associated with large apo A-I-containing lipoproteins. There was no correlation (r ‫؍‬ ؊0.01) between plasma PLTP and plasma phosphatidylcholine transfer activity (range, 3.5-10.5 mol ⅐ mL ؊1 ⅐ h ؊1 ), suggesting that PLTP may exist in active and inactive forms. Conclusion: This new ELISA will be of value for further studies of PLTP in health and disease.
Plasma phospholipid transfer protein (PLTP) 3 plays an important role in lipid transport. It mediates a net movement of phospholipids between vesicles and plasma HDLs (1 ) and between acceptor-donor pairs of HDLs, LDLs, and VLDLs (2, 3 ) . It also generates from spheroidal HDLs small lipid-poor apolipoprotein (apo) A-I-containing particles (4 -6 ) , which are thought to act as the primary acceptors of cell-derived cholesterol from peripheral tissues (7 ) . PLTP-mediated transfer of phospholipids is most efficient between HDL particles, presumably reflecting its physiologic function in the remodeling of HDLs. Pussinen et al. (8 ) have shown that the apo A-II/apo A-I molar ratio in HDLs influences PLTP-mediated particle interconversions, and have located the PLTPbinding domain in the NH 2 -terminal region of apo A-I (9 ) .
Cholesteryl ester transfer protein (CETP) also catalyzes the transfer of phospholipids between plasma lipoproteins (10 ) , and PLTP has been found to increase CETPmediated transfer of cholesteryl esters between VLDLs and HDLs (11 ) . Nevertheless, PLTP and CETP show neither cooperativity nor competition in the transfer of phospholipids between HDLs and LDLs (11 ) , suggesting that the two proteins transfer phospholipids by different mechanisms.
The apparent molecular mass of PLTP purified from human or pig plasma is between 69 and 81 kDa (4, (11) (12) (13) (14) . Human PLTP cDNA has been cloned and is 1750 bp in length, coding a signal sequence of 17 amino acids and a mature protein of 476 residues (13 ) .
Plasma PLTP activity has been reported to be increased in patients with non-insulin-dependent diabetes mellitus (15, 16 ) and obesity (17 ) , and to be increased by cigarette smoking (18 ) and alcohol consumption (19 ) . In view of the likely importance of PLTP in health and disease, reliable and accurate methods for measuring plasma PLTP concentrations are required. We have raised monoclonal antibodies (mAbs) against recombinant human PLTP (rhPLTP) expressed in Chinese hamster ovary (CHO) cells. Two of the mAbs reacted against purified human plasma PLTP and were used to develop a new sandwich ELISA.
Materials and Methods materials
Egg phosphatidylcholine (PC) and bovine phosphatidylserine were purchased from Sigma Chemical Company. 1-Palmitoyl-2-[1-14 C]-palmitoyl phosphatidylcholine (80 -120 mCi/mmol) was from NEN TM Life Science Products. Heparin (5000 kIU/L) was from Mochida Pharmaceutical Co. Block Ace was from Snow Brand Milk Products. Ni-NTA agarose was from QIAGEN. Phenyl-Sepharose CL-4B, heparin-Sepharose CL-6B, and protein A-Sepharose CL-4B were from Amersham Pharmacia Biotech. Human PLTP and PLTP purified from pig plasma were gifts from Dr. M. Jauhiainen (4, 14 ) .
subjects Blood samples were collected into EDTA-containing glass tubes (final concentration, 1 g/L; Terumo), and samples were immediately centrifuged at 2500g at 4°C for 10 min. Plasma was obtained from 132 apparently healthy subjects (75 males and 57 females). Their lipid profiles are summarized in Table 1 . Plasma samples were stored at Ϫ80°C. No subject was taking any medication known to affect plasma lipoproteins.
isolation of lipoproteins
The HDL 3 fraction (d ϭ 1.125-1.21 kg/L) was isolated from fresh human plasma by sequential preparative ultracentrifugation in a Beckman Ti 50.2 rotor, using solid KBr to adjust the density (20 ) . The washed HDL 3 was refloated at d ϭ 1.21 kg/L (14 ) ; dialyzed against phosphate-buffered saline (PBS), pH 7.4, containing 10 mmol/L Tris-HCl, 150 mmol/L NaCl, and 1 mmol/L EDTA; and stored at 4°C. Plasma HDL 2 -cholesterol (d ϭ 1.063-1.125 kg/L) and HDL 3 -cholesterol were quantified after preparative ultracentrifugation as described previously (20 ) . preparation of rhPLTP rhPLTP was prepared from CHO cell culture medium and purified using phenyl-Sepharose, Ni-NTA agarose, and heparin-Sepharose chromatography, as described previously (21, 22 ) . As a primary calibrator, heparin-purified rhPLTP was used. The purity of purified rhPLTP, subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and visualized by silver staining, was determined by gel scanning using the Intelligent Quantifier system (BioImage). This showed one 80-kDa protein band, representing Ͼ90% of total protein ( Fig.  1A ). Purified rhPLTP has been shown to be similar to plasma PLTP in PC transfer activity, remodeling of HDLs, and apo A-I cleavage activity (22 ) . preparation of mAbs against rhPLTP Balb/c mice were immunized with 25 g of purified rhPLTP (22 ) , and spleen cells from the mice were fused with Sp2/0 cells (23 ) . The supernatants of hybridoma cells were screened by ELISA using plates coated with purified rhPLTP (100 ng/well) and by immunoblotting. Positive hybridoma cells were cloned three times by limiting dilution and injected intraperitoneally into pristane-primed Balb/c mice. The IgG fraction was isolated from ascitic fluid using protein A-Sepharose CL-4B according to the manufacturer's instructions, dialyzed at 4°C against PBS, and stored at Ϫ80°C. The specificities of mAb113 and mAb114 were confirmed by immunoblotting against purified human plasma PLTP and human plasma. mAb isotype was characterized using the Mouse mAb Isotyping kit (Boehringer Mannheim) and was IgG2b and IgG1 for mAb113 and mAb114, respectively.
measurement of phospholipid transfer activity
Phospholipid transfer activity was measured as described by Damen et al. (24 ) , using [ 14 C]PC liposomes prepared as described by Cheung et al. (25 ) . A diluted plasma sample (100 L of a 1:50 dilution) was added to 400 L of reaction mixture containing washed HDL 3 (250 g of protein) and liposomes (75 nmol of PC) and incubated at 37°C for 30 min. Liposomes were then precipitated by the addition of 300 L of a solution containing 230 mmol/L NaCl, 92 mmol/L MnCl 2, 150 IU/L heparin (24 ) , and the radioactivity in the supernatant was measured. Phospholipid transfer activity was expressed as mol of PC transferred to HDL 3 per milliliter of plasma per hour. All assays were performed using the same batches of liposomes and HDL 3 . The intra-and interassay CVs (n ϭ 8) were 5.9% and 7.7%, respectively. The PC transfer activity of rhPLTP was a linear function of concentration up to 13.0 mol ⅐ mL Ϫ1 ⅐ h Ϫ1 . Polyclonal antibody raised against the rhPLTP in rabbits almost completely inhibited the PC transfer activities of both rhPLTP and normal human plasma (data not shown).
The PC transfer assay was tested by adding to each of three plasma samples of differing PC transfer activities (6.3, 9.5, and 11.0 mol ⅐ mL Ϫ1 ⅐ h Ϫ1 ) increasing amounts of rhPLTP of known transfer activities (0.7, 1.8, and 3.2 mol ⅐ mL Ϫ1 ⅐ h Ϫ1 ), and then measuring the PC transfer activities of the mixtures. The final measured PC transfer activities increased in a dose-dependent manner and were within 4 -20% of the predicted values (mean, 8.4%). measurement of pltp concentration mAb114 (100 L of a 5 mg/L solution in PBS) was coated on a microtiter plate (Nunc Immunoplate II) by incubation at 4°C overnight. The wells were then blocked with 200 L of PBS containing 40 g/L Block Ace (Snow Brand Milk Products) for 2 h at room temperature. After the plate was washed with 200 L of PBS containing 1 mL/L Tween 20, 100 L of the calibrator solution and diluted plasma samples (1:200) was added and incubated for 2 h at room temperature. After the plate was washed five times, 100 L of 1 mg/L biotinylated mAb113 was added to each well, and the mixture was incubated for 2 h at room temperature. After the plate was washed five times, 100 L of 1 mg/L horseradish peroxidase-conjugated streptavidin (Vector Laboratories) was added, and the mixture was incubated for 1 h. After the plate was washed, 100 L of substrate solution containing 0.25 g/L o-phenylenediamine and 0.15 mL/L H 2 O 2 was added to each well. After 30 min, the reaction was stopped by 
other analytical methods
Measurements of plasma total cholesterol, triacylglycerol, and HDL-cholesterol concentrations were performed in a Hitachi 7450 automated analyzer using commercial kits. Total HDL-cholesterol was measured after precipitation of apo B-containing lipoproteins with dextran sulfate and magnesium chloride. The LDL-cholesterol concentration was calculated according to Friedewald et al. (26 ) . The protein content of purified rhPLTP was determined with the BCA protein assay kit (Pierce), using bovine serum albumin as the calibrator. SDS-PAGE was performed by the Laemmli method (27 ) and immunoblotting as described by Towbin et al. (28 ) . SDS-PAGE for analysis of purified rhPLTP and plasma PLTP was performed using 5-20% polyacrylamide gels; proteins were detected with a silver staining kit (Daiichi Pure Chemical Co.) or by immunoblotting using a chemiluminescent reagent (NEN Life Science Products).
statistical analysis
Results are expressed as means Ϯ SD. Analysis of variance was used for group comparisons. Correlations were assessed by least-squares regression analysis. P Ͻ0.05 was considered statistically significant.
Results

characterization of anti-pltp mAbs
Two mAbs specific for PLTP were established: mAb113 and mAb114. Their specificities were examined by SDS-PAGE and immunoblotting under reducing and nonreducing conditions. When human plasma, purified plasma PLTP, and purified rhPLTP were subjected to SDS-PAGE, the mAbs reacted with a single protein (Fig. 1B) , the molecular mass of which (ϳ80 kDa) was similar to that previously reported for human PLTP (12 ) . Neither mAb inhibited PC transfer activity (data not shown). A sandwich ELISA for PLTP was established using mAb114 for capture and biotinylated mAb113 for detection. This system showed a dose-dependent response to heparin-purified rhPLTP (1:64 000 to 1:200), rhPLTP culture medium (1:2560 to 1:20), and plasma (1:2560 to 1:40; Fig. 2 ).
standardization of elisa for pltp concentration
For calibration of the ELISA, rhPLTP was purified from the culture medium of transfected CHO cells (22 ) . When subjected to SDS-PAGE and visualized by silver staining, the heparin-purified rhPLTP showed a single major 80-kDa band (Fig. 1A) , which represented Ͼ90% of the total protein in the preparation (as determined by gel scanning using the Intelligent Quantifier system). The protein concentration of this primary rhPLTP calibrator, assayed using a BCA protein kit with bovine serum albumin as calibrator, was typically 80 -90 mg/L.
To obtain a calibration curve for the ELISA, dilutions of the primary calibrator were made in PBS containing 1 mL/L Tween 20 to provide 0.156 -20.0 ng of rhPLTP protein per well (0.31-40.0 mg/L). As shown in Fig. 3 , the ELISA was linear up to 30 mg/L and suitable for quantifying PLTP concentrations as low as 1.2 mg/L. When the rhPLTP culture medium, as a secondary calibrator (1:2560 to 1:20), was diluted in PBS containing 1 mL/L Tween 20 to cover the PLTP concentration range 1.2-40.0 mg/L, the curve was identical to that attained with the primary calibrator ( Fig. 3) . To avoid potential nonlinearity caused by very low or high absorbance, the PLTP concentrations in plasma samples were measured using several dilutions (1:2560 to 1:40), and the least diluted aliquot that gave an absorbance value between 0.8 and 1.2 was chosen. The detergent Tween 20 was included in the diluent to avoid any effects of differences between samples in lipid/ apolipoprotein composition. We examined several detergent for sample dilution, including Triton X-100, CHAPS, CHAPSO, BIGCHAP, deoxy-BIGCHAP, n-octyl-␤-d-glucoside, n-heptyl-␤-d-thioglucoside, n-octyl-␤-d-maltoside, MEGA-9, sucrose monocaprate, and sodium cholate (Detergent Starter Kit II; Wako Pure Chemicals). Plasma samples diluted with buffer containing other detergents, such as n-dodecyl-␤-d-maltoside, gave higher absorbance, but the values for PLTP concentration did not differ from those obtained with PBS containing 1 mL/L Tween 20 (data not shown). Incubation of plasma samples at 56°C for 2 h, which as found by others (12, 25 ) produced complete loss of PC transfer activity, had no effect on the values obtained for PLTP concentration (data not shown).
When purified rhPLTP was added to samples of plasma in sufficient amounts to raise the total PLTP concentration by 2.5-13.2 mg/L, the final concentrations given by the ELISA averaged 102% of those predicted ( Table 2 ). The intra-and interassay CVs of the ELISA were Ͻ3.0% and 4.2%, respectively (n ϭ 8). No interference with the ELISA was observed with hemoglobin (10 g/L), bilirubin (0.2 g/L), or triacylglycerol (4.25 g/L).
plasma pltp concentrations in healthy subjects
PLTP concentrations and activities were measured in plasma samples from 132 healthy Japanese subjects (Table  3 ). Concentrations averaged 12.0 Ϯ 3.0 mg/L (mean Ϯ SD), with a range of 4.9 -20.5 mg/L. PC transfer activity averaged 6.3 Ϯ 1.3 mol ⅐ mL Ϫ1 ⅐ h Ϫ1 , with a range of 3.5-10.5 mol ⅐ mL Ϫ1 ⅐ h Ϫ1 . Mean PLTP-specific activity, calculated from these data, was 0.56 Ϯ 0.20 mol ⅐ h Ϫ1 ⅐ g Ϫ1 . There were no sex differences in PLTP concentration, PC transfer activity, or PLTP specific activity. There was no significant correlation between plasma PLTP concentration and plasma PC transfer activity (Table 4 and Fig. 4 ). In both sexes, plasma PLTP concentration was positively correlated with the concentrations of HDL-cholesterol, apo A-I, and HDL 2 -cholesterol ( Fig. 5 and Table 4 ) and was negatively correlated with triacylglycerol concentration (Table 4 ). In females but not in males, PLTP concentration was also negatively correlated with plasma apo B concentration. Values for PC transfer activity in plasma were not significantly correlated with any of the lipoprotein measurements in either sex (data not shown).
Discussion
Plasma PLTP activity was first described as mediating the transfer of phospholipids from triglyceride-rich lipoproteins to HDLs during lipolysis (2 ) . Phospholipid exchange activity is also possessed by CETP (29 ) , lipopolysaccharide-binding protein, and soluble CD14 (30 ) . An important difference between PLTP and CETP is that only the former transfers PC from liposomes to isolated HDLs (10, 11, 31, 32 ) . This forms the basis of plasma PLTP activity assays (24 ) and can be completely blocked by anti-PLTP antibodies (12, 32 ) . Recent studies in vitro have shown that PLTP catalyzes the remodeling of spheroidal HDLs into larger HDLs and small lipid-poor apo A-Icontaining particles (pre-␤ HDLs) (4, 5, 12 ) , the primary acceptors of cell-derived cholesterol in tissue culture (7 ) . Other findings in vitro and in transgenic animals have supported a role of PLTP in HDL remodeling and reverse cholesterol transport (6, (33) (34) (35) (36) (37) . PC transfer activity has been found in the plasma of all vertebrate species studied to date (38 ) . PLTP has also been shown to facilitate the transfer of cholesterol (36 ) , lipopolysaccharides (39 ) , and ␣-tocopherol (40 ) between lipoproteins. To date there have been few studies of the function of PLTP in the regulation of lipid transport in humans in vivo. In the absence of a reliable of immunoassay of plasma PLTP concentration, most clinical studies have been limited to measurements of phospholipid transfer activity (15) (16) (17) (18) (19) . For a better understanding of PLTP function, there is a need for reliable and sensitive methods for measuring PLTP concentration in plasma and other biological fluids. To this end, we prepared a series of mAbs against rhPLTP and used two of them to develop the sandwich ELISA. By SDS-PAGE and immunoblotting, both mAbs recognized a single protein of ϳ80 kDa under both reducing and nonreducing conditions, indicating that they react with a linear epitope of PLTP protein. We found that mAb113 cross-reacted with pig plasma PLTP, the amino acid sequence of which has 93% homology with human PLTP (41 ) . However, mAb114 did not cross-react with pig PLTP, demonstrating that the two mAbs recognize different epitopes on the PLTP molecule. The ELISA was found to be suitable for assaying plasma PLTP concentrations in the range 1.2-30.0 mg/L. No differences in dilution curves were observed between purified rh-PLTP (primary calibrator), rhPLTP culture medium (secondary calibrator), and human plasma. Intra-and interassay CVs were Ͻ5%. These results indicate that our ELISA is specific, accurate, reproducible, and sufficiently sensitive for a wide range of applications.
We used our ELISA to measure plasma PLTP concentrations in 132 healthy Japanese subjects. No sex difference was observed. No correlation existed with the PC transfer activity of plasma, suggesting that factors other than total PLTP concentration are more important as determinants of the rate of transfer PC into HDLs. Plasma PLTP concentration was positively correlated with the plasma HDL-cholesterol, HDL 2 -cholesterol, and apo A-I concentrations and negatively correlated with plasma triacylglycerol concentration. The correlation with HDL 2cholesterol is consistent with a report that on gel filtration chromatography PLTP coeluted with particles of similar size to HDL 2 (42 ) . Although PLTP has been shown to bind to both apo A-I and apo A-II in vitro (9 ) , our finding that the PLTP concentration correlated positively with the concentration of apo A-I but not with that of apo A-II suggests that binding to apo A-I-containing particles may predominate in vivo. Such particles might capture newly secreted PLTP, thereby retaining it in the plasma compartment. The apo A-I/apo A-II ratio of HDLs has been shown to be a determinant of PLTP-mediated HDL remodeling (8 ) , and PLTP cannot mediate the conversion of particles that lack apo A-I (9, 21 ) . Two immunoassays for plasma PLTP concentration have been developed by other groups. Desrumaux et al. (43 ) described a competitive ELISA that used a polyclonal rabbit antibody to purified human plasma PLTP. As determined by this assay, the plasma PLTP concentration in 30 healthy subjects was 3.95 Ϯ 1.04 mg/L (range, 1.98 -5.71 mg/L), which is much lower than the values obtained in the present study. No significant correlation was found between plasma PLTP concentration and either the HDL-cholesterol or triacylglycerol concentration. No measurements were made of apolipoproteins. Also contrasting with our results is the fact that Desrumaux et al. (43 ) found a strong correlation (r ϭ 0.79; P Ͻ0.001) between plasma PLTP concentration and plasma PC transfer activity. More recently, Huuskonen et al. (44 ) developed an assay that uses a mAb for capture and a polyclonal rabbit antibody for detection, both raised against rhPLTP expressed in Escherichia coli. This assay gave plasma PLTP concentrations of 15.6 Ϯ 5.1 mg/L (range, 2.3-33.4 mg/L) in 159 Finnish subjects, which is similar to those obtained by us in Japanese subjects with our assay. As in the present study, Huuskonen et al. (44 ) found no correlation between plasma PLTP concentration and plasma PC transfer activity (r ϭ Ϫ0.06).
Thus, our results are in good agreement with those obtained by Huuskonen et al. (44 ) in relation to both the absolute values of plasma PLTP concentration in healthy subjects and the absence of any correlation with plasma PC transfer activity. The apparent inconsistency between these results and those reported by Desrumaux et al. (43 ) probably cannot be explained by differences in sample sizes or in the genetic background, dietary habits, or life-styles of the subjects. A theoretical possibility is that there are catalytically active and inactive forms of PLTP in plasma and that both our immunoassay and that of Huuskonen et al. (44 ) quantify both forms, but that of Desrumaux et al. (43 ) quantifies only the active form. We recently studied the distribution of PLTP mass and PC transfer activity in human plasma fractions separated by size exclusion chromatography. Evidence was obtained that there are indeed active and inactive species of PLTP, that the active form constitutes only ϳ20% of the total, and that the two species are associated with particles of different sizes [Oka et al. The distribution of phospholipid transfer protein (PLTP) in human plasma: presence of two forms of PLTP, one catalytically active and the other inactive, submitted for publication].
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